AbbVie Inc. (ABBV)
NYSE • Currently up 8.86 (+4.35%) in today's trading session
4 members of Congress have disclosed 15 trades in AbbVie Inc. (ABBV) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 31 October 2025. The most active traders have been Lisa McClain (6), Marjorie Taylor Greene (4), and Jared Moskowitz (3). Aggregate disclosed activity totals roughly $88K in purchases and $32K in sales (midpoint estimates from bracketed disclosure amounts).
AbbVie Inc. is currently trading at $212.75, positioned at 53% of its 52-week range ($176.57 – $244.81).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Not available in the US.
Past Performance is not an indication of future results.
*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.
AbbVie Inc. Price History and Technical Analysis
Congressional Trading Activity for ABBV
| Lisa McClain | 31 Oct 2025 | 21 Nov 2025 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Lisa McClain | 30 Oct 2025 | 21 Nov 2025 | Purchase | Stock | $1,001 - $15,000 | -4.74% | |
| Lisa McClain | 30 Oct 2025 | 21 Nov 2025 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Marjorie Taylor Greene | 4 Aug 2025 | 15 Aug 2025 | Purchase | Stock | $1,001 - $15,000 | +8.76% | |
| Lisa McClain | 22 Jul 2025 | 13 Aug 2025 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Lisa McClain | 22 Jul 2025 | 13 Aug 2025 | Purchase | Stock | $1,001 - $15,000 | +16.02% | |
| Marjorie Taylor Greene | 5 May 2025 | 6 May 2025 | Purchase | Stock | $1,001 - $15,000 | +9.38% | |
| Jared Moskowitz | 7 Apr 2025 | 9 May 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Marjorie Taylor Greene | 17 Mar 2025 | 19 Mar 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Jared Moskowitz | 15 Jan 2025 | 10 Feb 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Jared Moskowitz | 15 Jan 2025 | 10 Feb 2025 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Marjorie Taylor Greene | 20 Nov 2024 | 21 Nov 2024 | Purchase | Stock | $1,001 - $15,000 | N/A | |
| Josh Gottheimer | 8 Nov 2023 | 8 Dec 2023 | Sale | Stock | $1,001 - $15,000 | N/A | |
| Josh Gottheimer | 6 Mar 2023 | 20 Apr 2023 | Purchase | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
AMZN
Amazon.com, Inc.
JPM
JPMorgan Chase & Co.
TSM
Taiwan Semiconductor Manufacturing Company Limited
Frequently Asked Questions about ABBV
- Which members of Congress have traded ABBV?
- 4 members of Congress have disclosed 15 trades in AbbVie Inc. (ABBV) under the STOCK Act. The most active traders are Lisa McClain, Marjorie Taylor Greene, and Jared Moskowitz.
- When was ABBV most recently disclosed by Congress?
- The most recent ABBV disclosure was a sale by Lisa McClain on 31 October 2025.
- What is the total disclosed congressional trading volume for ABBV?
- Members of Congress have disclosed approximately $88K in ABBV purchases and $32K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
- How can I track new congressional trades in ABBV?
- This ABBV page updates as soon as new STOCK Act disclosures are filed for AbbVie Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track ABBV in Congress
See when politicians buy or sell this stock